These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 29890736

  • 1. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).
    Pires de Mello CP, Drusano GL, Rodriquez JL, Kaushik A, Brown AN.
    Viruses; 2018 Jun 09; 10(6):. PubMed ID: 29890736
    [Abstract] [Full Text] [Related]

  • 2. Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a.
    Gallegos KM, Drusano GL, D Argenio DZ, Brown AN.
    J Infect Dis; 2016 Oct 15; 214(8):1192-7. PubMed ID: 27496974
    [Abstract] [Full Text] [Related]

  • 3. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.
    Franco EJ, Pires de Mello CP, Brown AN.
    Viruses; 2021 Apr 27; 13(5):. PubMed ID: 33925551
    [Abstract] [Full Text] [Related]

  • 4. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
    Pires de Mello CP, Tao X, Kim TH, Bulitta JB, Rodriquez JL, Pomeroy JJ, Brown AN.
    Antimicrob Agents Chemother; 2018 Jan 27; 62(1):. PubMed ID: 29109164
    [Abstract] [Full Text] [Related]

  • 5. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines.
    Franco EJ, Rodriquez JL, Pomeroy JJ, Hanrahan KC, Brown AN.
    Antivir Chem Chemother; 2018 Jan 27; 26():2040206618807580. PubMed ID: 30354193
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A.
    Rattanaburee T, Junking M, Panya A, Sawasdee N, Songprakhon P, Suttitheptumrong A, Limjindaporn T, Haegeman G, Yenchitsomanus PT.
    Antiviral Res; 2015 Dec 27; 124():83-92. PubMed ID: 26542647
    [Abstract] [Full Text] [Related]

  • 7. Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1.
    Chen WC, Tseng CK, Lin CK, Wang SN, Wang WH, Hsu SH, Wu YH, Hung LC, Chen YH, Lee JC.
    Virulence; 2018 Jan 01; 9(1):588-603. PubMed ID: 29338543
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses.
    Yu JS, Tseng CK, Lin CK, Hsu YC, Wu YH, Hsieh CL, Lee JC.
    Antiviral Res; 2017 Jan 01; 137():49-57. PubMed ID: 27847245
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
    Abdul Ahmad SA, Palanisamy UD, Tejo BA, Chew MF, Tham HW, Syed Hassan S.
    Virol J; 2017 Nov 21; 14(1):229. PubMed ID: 29162124
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3.
    Vigani AG, Gonçales ES, Pavan MH, Genari F, Tozzo R, Lazarini MS, Fais V, Feltrin A, Gonçales NS, Gonçales FL.
    Braz J Infect Dis; 2012 Nov 21; 16(3):232-6. PubMed ID: 22729189
    [Abstract] [Full Text] [Related]

  • 15. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS, Wu KX, Chen KC, Ng MM, Chu JJ.
    Antivir Ther; 2011 Nov 21; 16(8):1203-18. PubMed ID: 22155902
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection.
    Pawlotsky JM, Flisiak R, Sarin SK, Rasenack J, Piratvisuth T, Chuang WL, Peng CY, Foster GR, Shah S, Wedemeyer H, Hézode C, Zhang W, Wong KA, Li B, Avila C, Naoumov NV, VITAL-1 study team.
    Hepatology; 2015 Oct 21; 62(4):1013-23. PubMed ID: 26118427
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Novel antiviral activity of bromocriptine against dengue virus replication.
    Kato F, Ishida Y, Oishi S, Fujii N, Watanabe S, Vasudevan SG, Tajima S, Takasaki T, Suzuki Y, Ichiyama K, Yamamoto N, Yoshii K, Takashima I, Kobayashi T, Miura T, Igarashi T, Hishiki T.
    Antiviral Res; 2016 Jul 21; 131():141-7. PubMed ID: 27181378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.